← back to database
Deerfield
HQ · New York
Deerfield invests across the healthcare ecosystem, from early-stage companies to mature private and public companies, with interests in therapeutics, medical devices, healthcare services, diagnostics, and digital health. Its internal R&D and commercialization infrastructure can help advance early therapeutic assets.
Stage focus
Specialization
Generalist / Specialist
Specialist
Latest fund size
Over $600M closed
Latest fund vintage
2025
Other specialization
Therapeutics, medical devices, healthcare services, diagnostics, and digital health. Deerfield also develops assets through its internal Deerfield Discovery and Development engine and supports care-delivery innovation.
Investing team
- Jim FlynnManaging Partner; investment and portfolio oversight ()
- Stephen AnastosManaging Director, Healthcare Services; joined to focus on early and growth-stage healthcare technology and services investments ()
- Michael BergenManaging Director, Medical Technologies ()
- Brian Chow, Ph.D.Managing Director, Therapeutics ()
- Anne DaubPartner, Therapeutics ()
- Frank Nestle, M.D.Partner and Chief Executive Officer, Deerfield Discovery and Development ()
Notable investments
Boulevard Bio — 2026-08 — New initial seed-stage venture transaction Atlas Data Storage — 2025-05 — New initial seed-stage venture transaction
Sources
deerfield.com/what-we-do/investment ↗deerfield.com/about/contact ↗deerfield.com/teams/investment ↗deerfield.com/team ↗deerfield.com/news/deerfield-management-closes-over-600-million-healthcare-venture-fund ↗deerfield.com/what-we-do/investment/portfolio/companies/boulevard-bio ↗deerfield.com/what-we-do/investment/portfolio/companies/atlas-data-storage ↗linkedin.com/company/deerfield-management ↗deerfield.com ↗